Variants of human seminal acrosin inhibitor (HUSI-II) which inhibit human leukocyte elastase.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Variants of human seminal acrosin inhibitor (HUSI-II) which inhibit human leukocyte elastase.

Biomedica biochimica acta - 1 Jan 1991

Collins J, Taube W, Fink E, Möritz A, Fritz H

Abstract excerpt

A cDNA coding for human seminal inhibitor II was fused to the ompA-gene leader peptide for the expression in E. coli. The secreted protein is biologically active and correctly processed. Inhibitors of human leukocyte elastase were constructed by site-directed mutagenesis.

Topics

Amino Acid Sequence
Cloning, Molecular
Escherichia coli
Genetic Variation
Humans
In Vitro Techniques
Leukocyte Elastase
Male
Molecular Sequence Data
Mutagenesis, Site-Directed
Pancreatic Elastase
Proteinase Inhibitory Proteins, Secretory
Proteins
Recombinant Fusion Proteins
Semen
Serine Proteinase Inhibitors

Source

Open in PubMed

Identifiers

PMID: 1801743

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-1801743-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics